RIGL20251121P37
RIGL Nov 21 2025 37.00 Put (RIGL251121P00037000)
option OPRA

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.